Видео ютуба по тегу Elililly

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
LILIT HOVHANNISYAN - ELI LILIT
LILIT HOVHANNISYAN - ELI LILIT
Внутри золотой лихорадки GLP-1: генеральный директор Eli Lilly о новых открытиях, зависимости и п...
Внутри золотой лихорадки GLP-1: генеральный директор Eli Lilly о новых открытиях, зависимости и п...
Eli Lilly CFO on $1 Billion AI Drug Lab Investment
Eli Lilly CFO on $1 Billion AI Drug Lab Investment
Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman
Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Eli Lilly reaches $1 trillion market value | REUTERS
Eli Lilly reaches $1 trillion market value | REUTERS
My Focus
My Focus
Eli Lilly in negotiations with Trump administration for the next pharma deal
Eli Lilly in negotiations with Trump administration for the next pharma deal
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Дэвид А. Рикс, председатель и генеральный директор Eli Lilly and Company
Дэвид А. Рикс, председатель и генеральный директор Eli Lilly and Company
Я обновил свой рейтинг акций Eli Lilly | Анализ акций LLY
Я обновил свой рейтинг акций Eli Lilly | Анализ акций LLY
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results
Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
The David Rubenstein Show: Eli Lilly CEO Dave Ricks
The David Rubenstein Show: Eli Lilly CEO Dave Ricks
Cramer's Mad Dash: Eli Lilly
Cramer's Mad Dash: Eli Lilly
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock | LLY Stock | NVO Stock
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock | LLY Stock | NVO Stock